Acquired Anosmia Affects Quality of Life More Than Congenital Anosmia

Navigating Life Without Smell: The Enduring Impact of Anosmia

Olfactory dysfunction, ranging from partial (hyposmia) to complete (anosmia) loss of smell, is a significant clinical concern affecting an estimated 29% of the population and posing risks from undetected hazards like gas leaks or spoiled food [1, 2]. While etiologies include trauma and chronic rhinosinusitis, the COVID-19 pandemic has dramatically increased the prevalence of acquired anosmia, with many patients reporting persistent symptoms months or years post-infection [3, 4, 5]. This enduring sensory deficit is a recognized component of long COVID, often diminishing quality of life alongside fatigue and dyspnea [6, 7]. As effective pharmacological treatments remain limited, a new study offers valuable insights into how the origin and duration of anosmia shape the patient's experience and psychological adaptation over time [8, 9, 10].

Comparing Anosmia Etiologies and Durations

To delineate how permanent anosmia affects quality of life, a recent study compared distinct patient populations based on the onset and duration of their condition. The investigation included 59 patients with post-viral or idiopathic anosmia who had sought medical evaluation for their olfactory complaints. This cohort was assessed using the Questionnaire of Olfactory Disorders (QOD), a validated instrument that quantifies the patient's lived experience by measuring perceived impairment, subjective disturbance, and psychological coping ability. To isolate the effects of duration and adaptation, the researchers stratified participants into three well-defined groups: patients with persistent acquired anosmia (PerA), defined as a duration of 6 months to 2 years; patients with prolonged acquired anosmia (ProA), with a duration of 10 years or more; and a reference group of individuals with isolated congenital anosmia (ICA). This design, which excluded patients with intermediate durations to minimize recall bias, allowed for a direct comparison between those who lost their sense of smell and those who never had it.

Differential Impact on Perceived Impairment

The study revealed that the experience of impairment is fundamentally different for those who acquire anosmia versus those born with it. Analysis of scores from the Questionnaire of Olfactory Disorders Nuisance Score (QOD-NS) and the work-domain Visual Analog Scale (QOD-VAS), which measure daily life frustrations and professional challenges, showed that perceived impairment was significantly higher in both the persistent (PerA) and prolonged (ProA) acquired anosmia groups compared to the isolated congenital anosmia (ICA) group. This finding suggests that the memory of smell and the experience of its loss contribute to a greater subjective burden. Critically, the researchers found no significant difference in these impairment scores between the PerA and ProA groups. This indicates that for individuals with acquired anosmia, the profound sense of impairment does not appear to diminish substantially over time, remaining high even after a decade. The data consistently support the conclusion that acquired anosmia has a greater impact on quality of life than congenital anosmia.

Coping Mechanisms Over Time

While perceived impairment from acquired anosmia remains high over the long term, the study's findings on psychological adaptation tell a different story. Using the Questionnaire of Olfactory Disorders Psychological Score (QOD-PS) to assess coping, the researchers found that the prolonged acquired anosmia (ProA) group demonstrated significantly better coping ability than the persistent acquired anosmia (PerA) group. This suggests that while the functional deficit persists, patients who have lived with the condition for a decade or more develop more effective psychological strategies to manage its impact. Further supporting this observation, the study found that coping scores in the ProA group were comparable to those in the isolated congenital anosmia (ICA) group. This key finding implies that over a long enough period, individuals who lose their sense of smell can achieve a level of psychological adjustment similar to those who have never experienced olfaction. For clinicians, this highlights a crucial distinction: while the sense of loss is permanent, a patient's ability to cope can improve, suggesting a potential role for counseling and supportive interventions focused on fostering adaptive strategies.

References

1. Alharbi AS, Abdelazim M, Alshammari AS, et al. Vericiguat Enhances Olfactory Function in Post-Infectious Anosmia: A Randomized Pilot Double-Blind Placebo-Controlled Trial. American Journal of Rhinology & Allergy. 2025. doi:10.1177/19458924251364571

2. Ferrara G, Palomares SM, Anastasi G, et al. Anosmia, dysgeusia and malnutrition in chronic kidney disease: A systematic review.. Nefrologia. 2025. doi:10.1016/j.nefroe.2025.02.002

3. López‐León S, Wegman-Ostrosky T, Perelman C, et al. More than 50 long-term effects of COVID-19: a systematic review and meta-analysis. Scientific Reports. 2021. doi:10.1038/s41598-021-95565-8

4. Hannum ME, Ramirez VA, Lipson SJ, et al. Objective sensory testing methods reveal a higher prevalence of olfactory loss in COVID-19–positive patients compared to subjective methods: A systematic review and meta-analysis. Chemical Senses. 2020. doi:10.1093/chemse/bjaa064

5. Trott M, Driscoll R, Pardhan S. The prevalence of sensory changes in post-COVID syndrome: A systematic review and meta-analysis.. Frontiers in medicine. 2022. doi:10.3389/fmed.2022.980253

6. Malik P, Patel K, Pinto C, et al. Post‐acute COVID‐19 syndrome (PCS) and health‐related quality of life (HRQoL)—A systematic review and meta‐analysis. Journal of Medical Virology. 2021. doi:10.1002/jmv.27309

7. Patel UK, Mehta N, Patel A, et al. Long-Term Neurological Sequelae Among Severe COVID-19 Patients: A Systematic Review and Meta-Analysis.. Cureus. 2022. doi:10.7759/cureus.29694

8. Mehraeen E, Yarmohammadi S, Mirzapour P, et al. Treatments for Olfactory Dysfunction in COVID-19: A Systematic Review.. International archives of otorhinolaryngology. 2024. doi:10.1055/s-0044-1786046

9. Nag AK, Saltagi AK, Saltagi MZ, et al. Management of Post-Infectious Anosmia and Hyposmia: A Systematic Review.. The Annals of otology, rhinology, and laryngology. 2023. doi:10.1177/00034894221118186

10. Vance DE, Bene VAD, Kamath V, et al. Does Olfactory Training Improve Brain Function and Cognition? A Systematic Review. Neuropsychology Review. 2023. doi:10.1007/s11065-022-09573-0